Indivior Pharmaceuticals, Inc. Share Price
Stocks
INDV
US45579U1097
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Nasdaq
01:30:00 17/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 32.45 USD | -3.48% |
|
-9.43% | -9.56% |
| Market Cap | 382.95Cr 340.41Cr 315.51Cr 287.06Cr 541.7Cr 36TCr 550.38Cr 3.79TCr 1.49TCr 19TCr 1.44TCr 1.41TCr 60TCr | P/E 2026 * |
8.72x | P/E 2027 * | 7.9x |
|---|---|---|---|---|---|
| Enterprise Value | 381.7Cr 339.3Cr 314.48Cr 286.13Cr 539.93Cr 36TCr 548.59Cr 3.78TCr 1.48TCr 19TCr 1.43TCr 1.4TCr 60TCr | EV / Sales 2026 * |
2.87x | EV / Sales 2027 * | 2.33x |
| Free-Float |
98.2% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| INDV | Delayed | |
CBOE
| INDV | Real-time | |
|
Boerse Muenchen
| E7P | Real-time | |
|
Deutsche Boerse AG
| E7P | Delayed | |
|
Tradegate
| E7P | Real-time | |
|
Xetra
| E7P | Delayed |
Last Transcript: Indivior Pharmaceuticals, Inc.
| 1 day | -3.48% | ||
| 1 week | -9.43% | ||
| Current month | -9.48% | ||
| 1 month | -5.53% | ||
| 3 months | -20.05% | ||
| 6 months | +2.98% | ||
| Current year | -9.56% |
| 1 week | 32.31 |  | 36.32 |
| 1 month | 32.31 | | 37.05 |
| Current year | 27.68 | | 42.81 |
| 1 year | 23.72 | | 42.81 |
| 3 years | 7.33 | | 42.81 |
| 5 years | 7.33 | | 42.81 |
| 10 years | 1.75 | | 42.81 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 27/08/26 | Buy | Controller/Auditor | 1,500 | 0.0012% | ||
| 05/08/26 | Buy | Controller/Auditor | 1,500 | 0.0012% | ||
| 10/07/26 | Sell | Chief Scientific Officer | -18,586 | 0.0152% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.48% | -9.43% | +31.43% | +67.27% | 396.76Cr | |
| +0.43% | +6.59% | +53.41% | +103.85% | 1,11600Cr | |
| +0.90% | -2.25% | +33.02% | +62.23% | 61TCr | |
| +0.71% | +3.24% | +25.81% | +93.86% | 50TCr | |
| -0.13% | +5.98% | +32.91% | +50.39% | 37TCr | |
| +0.52% | +0.24% | +73.92% | +40.15% | 36TCr | |
| -0.95% | +4.70% | +19.51% | +43.00% | 29TCr | |
| -1.98% | +3.73% | -0.86% | +13.43% | 26TCr | |
| -0.35% | +4.25% | +46.21% | +50.76% | 23TCr | |
| -0.75% | +3.32% | +32.53% | +97.21% | 20TCr | |
| Average | -0.51% | +2.70% | +34.79% | +62.21% | 39.34TCr | |
| Weighted average by Cap. | +0.12% | +4.14% | +39.12% | +71.36% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 133.2Cr 118.4Cr 109.74Cr 100Cr 188.41Cr 13TCr 191.43Cr 1.32TCr 517.19Cr 6.6TCr 499.89Cr 489.24Cr 21TCr | 139.95Cr 124.4Cr 115.31Cr 104.91Cr 197.97Cr 13TCr 201.14Cr 1.39TCr 543.42Cr 6.93TCr 525.24Cr 514.06Cr 22TCr |
| Net income | 47Cr 42Cr 39Cr 36Cr 67Cr 4.5TCr 68Cr 469.68Cr 184.15Cr 2.35TCr 177.99Cr 174.2Cr 7.49TCr | 53Cr 47Cr 44Cr 40Cr 75Cr 5.03TCr 76Cr 524.85Cr 205.78Cr 2.62TCr 198.9Cr 194.66Cr 8.37TCr |
| Net Debt | -1.25Cr -1.11Cr -1.03Cr -93.7L -1.77Cr -118.63Cr -1.8Cr -12Cr -4.85Cr -62Cr -4.69Cr -4.59Cr -197.35Cr | -57Cr -51Cr -47Cr -43Cr -81Cr -5.41TCr -82Cr -564.49Cr -221.33Cr -2.82TCr -213.92Cr -209.37Cr -9TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/26/16 | $32.45 | -3.48% | 42,91,168 |
| 15/26/15 | $33.62 | -1.58% | 17,51,197 |
| 14/26/14 | $34.16 | -3.56% | 27,81,192 |
| 13/26/13 | $35.42 | -1.77% | 19,30,513 |
| 12/26/12 | $36.06 | +0.64% | 74,74,012 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- INDV Stock
Select your edition
All financial news and data tailored to specific country editions
